Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burkhard Leeb

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Rheuma Plus|September 28, 2020
[Education in Times of the Pandemic, Change of Paradigms?]Burkhard Leeb
Rheuma Plus|March 1, 2021
[There is no Getting Around Corona]Burkhard Leeb
Rheuma Plus|August 16, 2021
[Time is Rushing by-<i>Rheuma Plus</i> is Rushing Along]Burkhard Leeb
Medwave|April 21, 2018
Comments on Alegría and Irarrázaval (2017): Is diacerein an alternative for the treatment of osteoarthritis?Burkhard Leeb
Rheuma Plus|April 1, 2020
[There is Something Else Still]Burkhard Leeb
Rheuma Plus|November 11, 2020
[Second Wave, Third Wave, Does It Matter?]Burkhard Leeb
Current Medical Research and Opinion|July 4, 2002
Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the management of inflammatory painErnst-Martin Lemmel, Burkhard Leeb, Johan De Bast, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|July 18, 2020
[Pain and pain management in old age: special features and recommendations]Georg Pinter, Waltraud Stromer, Josef Donnerer, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|July 19, 2020
[Pain treatment in old age: special features and recommendations]Georg Pinter, Waltraud Stromer, Josef Donnerer, et al.
Annals of the Rheumatic Diseases|July 27, 2012
Rituximab in psoriatic arthritis: an exploratory evaluationEsther Jimenez-Boj, Tanja A Stamm, Martina Sadlonova, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Rheuma Plus|September 28, 2020
[Education in Times of the Pandemic, Change of Paradigms?]Burkhard Leeb
Rheuma Plus|March 1, 2021
[There is no Getting Around Corona]Burkhard Leeb
Rheuma Plus|August 16, 2021
[Time is Rushing by-<i>Rheuma Plus</i> is Rushing Along]Burkhard Leeb
Medwave|April 21, 2018
Comments on Alegría and Irarrázaval (2017): Is diacerein an alternative for the treatment of osteoarthritis?Burkhard Leeb
Rheuma Plus|April 1, 2020
[There is Something Else Still]Burkhard Leeb
Rheuma Plus|November 11, 2020
[Second Wave, Third Wave, Does It Matter?]Burkhard Leeb
Current Medical Research and Opinion|July 4, 2002
Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the management of inflammatory painErnst-Martin Lemmel, Burkhard Leeb, Johan De Bast, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|July 18, 2020
[Pain and pain management in old age: special features and recommendations]Georg Pinter, Waltraud Stromer, Josef Donnerer, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|July 19, 2020
[Pain treatment in old age: special features and recommendations]Georg Pinter, Waltraud Stromer, Josef Donnerer, et al.
Annals of the Rheumatic Diseases|July 27, 2012
Rituximab in psoriatic arthritis: an exploratory evaluationEsther Jimenez-Boj, Tanja A Stamm, Martina Sadlonova, et al.
Pageof 2